Literature DB >> 8393366

Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer.

C B Ambrosone1, U Rao, A M Michalek, K M Cummings, C J Mettlin.   

Abstract

BACKGROUND: Previous research has demonstrated that there is clustering of cancer among relatives of patients with lung cancer and that women may be at a greater risk than men, regardless of their smoking histories.
METHODS: The authors conducted a study to test the hypotheses that this predisposition varies by the histologic type of tumor and that women with particular histologic types will report more first-degree relatives with cancer than will men with the same cell type. The analyses were based on 872 patients with histologically confirmed lung cancer who had been admitted to Roswell Park Cancer Institute, Buffalo, New York, between 1982 and 1987.
RESULTS: More patients with squamous and large cell carcinomas reported two or more relatives with cancer, and overall, women reported more family history of cancer. Among patients with squamous cell carcinoma, this difference between men and women was significant (P < 0.05). Among patients younger than 57 years, those with squamous cell were the most likely to report a family history of cancer (P < 0.01). A similar trend was observed for smoking. Persons with small cell and squamous cell carcinomas who were nonsmokers or had smoked 1-20 years had three times the risk of a family history of cancer than did those with large cell and adenocarcinomas (odds ratio [OR] = 3.01; confidence interval [ci] = 1.38-6.63), in contrast to those who had smoked more than 20 years (OR = 0.85; ci = 0.62-1.62).
CONCLUSIONS: Squamous cell carcinoma is most associated with familial clustering of cancer, particularly among women, persons younger than 57 years, and individuals who smoked for fewer than 20 years.

Entities:  

Mesh:

Year:  1993        PMID: 8393366     DOI: 10.1002/1097-0142(19930815)72:4<1192::aid-cncr2820720410>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Quantitative assessment of common genetic variants on chromosome 5p15 and lung cancer risk.

Authors:  Hongyu Wu; Ren Zhu
Journal:  Tumour Biol       Date:  2014-03-12

2.  Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies.

Authors:  De-ping Zhao; Chen-lu Yang; Xiao Zhou; Jia-an Ding; Ge-ning Jiang
Journal:  Mol Genet Genomics       Date:  2014-06-07       Impact factor: 3.291

3.  p53 gene mutations, and CYP1A1 and GSTM1 genotypes in pulmonary squamous cell carcinomas.

Authors:  S Ohshima; Y Xu
Journal:  Mol Pathol       Date:  1997-04

4.  The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer.

Authors:  Ning Li; Kang Shao; Zhaoli Chen; Bin Qiu; Zhen Wang; Fengwei Tan; Jiwen Wang; Xiaogang Tan; Baozhong Li; Meihua Xiong; Fang Zhou; Jie He
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

Authors:  Maria Teresa Landi; Nilanjan Chatterjee; Kai Yu; Lynn R Goldin; Alisa M Goldstein; Melissa Rotunno; Lisa Mirabello; Kevin Jacobs; William Wheeler; Meredith Yeager; Andrew W Bergen; Qizhai Li; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Michael Thun; Ryan Diver; Martin Oken; Jarmo Virtamo; Demetrius Albanes; Zhaoming Wang; Laurie Burdette; Kimberly F Doheny; Elizabeth W Pugh; Cathy Laurie; Paul Brennan; Rayjean Hung; Valerie Gaborieau; James D McKay; Mark Lathrop; John McLaughlin; Ying Wang; Ming-Sound Tsao; Margaret R Spitz; Yufei Wang; Hans Krokan; Lars Vatten; Frank Skorpen; Egil Arnesen; Simone Benhamou; Christine Bouchard; Andres Metspalu; Andres Metsapalu; Tonu Vooder; Mari Nelis; Kristian Välk; John K Field; Chu Chen; Gary Goodman; Patrick Sulem; Gudmar Thorleifsson; Thorunn Rafnar; Timothy Eisen; Wiebke Sauter; Albert Rosenberger; Heike Bickeböller; Angela Risch; Jenny Chang-Claude; H Erich Wichmann; Kari Stefansson; Richard Houlston; Christopher I Amos; Joseph F Fraumeni; Sharon A Savage; Pier Alberto Bertazzi; Margaret A Tucker; Stephen Chanock; Neil E Caporaso
Journal:  Am J Hum Genet       Date:  2009-10-15       Impact factor: 11.025

6.  Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer.

Authors:  Ying Gao; Alisa M Goldstein; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Margaret A Tucker; Neil E Caporaso; Lynn Goldin; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

Review 7.  Radiological-pathological correlation in intratumoural tissue components of solid lung tumours.

Authors:  E Quaia; E Baratella; R Pizzolato; R Bussani; M A Cova
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

8.  Clinicopathological characteristics and prognosis of non-small cell lung cancer patients associated with a family history of lung cancer.

Authors:  Shuji Haraguchi; Kiyoshi Koizumi; Iwao Mikami; Okamoto Junichi; Yoshihito Iijima; Takayuki Ibi; Kazuo Shimizu
Journal:  Int J Med Sci       Date:  2011-11-30       Impact factor: 3.738

9.  Microsatellite instability in female non-small-cell lung cancer patients with familial clustering of malignancy.

Authors:  K Suzuki; T Ogura; T Yokose; I Sekine; K Nagai; T Kodama; K Mukai; Y Nishiwaki; H Esumi
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.

Authors:  Albert Rosenberger; Thomas Illig; Katrin Korb; Norman Klopp; Vera Zietemann; Gabi Wölke; Eckart Meese; Gerhard Sybrecht; Florian Kronenberg; Matthias Cebulla; Maria Degen; Peter Drings; Andreas Gröschel; Nikolaus Konietzko; Karsten Grosse Kreymborg; Karl Häussinger; Gerd Höffken; Bettina Jilge; You-Dschun Ko; Harald Morr; Christine Schmidt; E-Wilhelm Schmidt; Dagmar Täuscher; Heike Bickeböller; H-Erich Wichmann
Journal:  BMC Cancer       Date:  2008-02-25       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.